Drug Trial Radar · NCT06917404
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
466
Planned (sponsor's estimate)
Start
May 29, 2025
Primary completion
Jul 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Paradigm Biopharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.
Conditions
- Osteoarthritis, Knee
Interventions
Pentosan Polysulfate Sodium twice weeklyDrug
Subcutaneous injection, 2 mg/kg twice weekly for 6 weeks
PlaceboDrug
Placebo, subcutaneous injection, twice weekly for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline at Day 112 in knee pain as assessed by the weekly average of daily pain (ADP) score on the numerical rating scale (NRS) 11-point (0-10) scale.Time frame: Baseline, Daily to Day 112
Locations
57 sites in 4 countries. Site status is shown where the registry gives one.
Onyx Clinical Research-Peoria
Peoria, Arizona
Del Sol Research Management, LLC
Tucson, Arizona
Orange County Research Institute
Anaheim, California
Core Healthcare Group
Cerritos, California
Triwest Research Center
Chula Vista, California
Seaside Medical Group
Oceanside, California
Paragon RX Clinical
Santa Ana, California
Encompass Clinical Research
Spring Valley, California
Focus Clinical Research
West Hills, California
Clinical Research of West Florida - Clearwater
Clearwater, Florida
GNP Research
Cooper City, Florida
Arrow Clinical Trials
Daytona Beach, Florida
AGA Clinical Trials
Hialeah, Florida
Evolution Clinical Trials
Miami, Florida
Well Pharma Medical Research
Miami, Florida
K2 Medical Research
Orlando, Florida
Progressive Medical Research
Port Orange, Florida
Phoenix Clinical Research
Tamarac, Florida
Conquest Research
Winter Park, Florida
Chicago Clinical Research, Inc
Chicago, Illinois
Northwestern University
Chicago, Illinois
Sinai Hospital of Baltimore
Baltimore, Maryland
Profound Research
Farmington Hills, Michigan
Insight Research Institute
Flint, Michigan
Rochester Medical Group
Rochester Hills, Michigan
Onyx Clinical Research - Rochester Hills
Troy, Michigan
Physician Research Collaboration
Lincoln, Nebraska
Alpine Healthcare Family Practice
Las Vegas, Nevada
Drug Trials America
Hartsdale, New York
Groth Pain & Spine - Long Island, NY
Mineola, New York
IMA Clinical Research Manhattan
New York, New York
Groth Pain and Spine Management
Smithtown, New York
FutureSearch Trials of Neurology
Austin, Texas
FutureSearch Trials of Dallas
Dallas, Texas
El Paso Clinical Trials
El Paso, Texas
Vilo Research Group
Houston, Texas
DM Clinical Research
Houston, Texas
Clinical Trial Network
Houston, Texas
Epic Clinical Research
Lewisville, Texas
Quality Research Inc.
San Antonio, Texas
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.